Dr. Gilbert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of Alabama HospitalResidency, 1994 - 1998
- University of Alabama School of MedicineClass of 1994
Certifications & Licensure
- TN State Medical License 2006 - 2026
- LA State Medical License 1995 - 2025
- AL State Medical License 1995 - 2020
- MD State Medical License 1998 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 124 citationsSafety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancerJanice M. Mehnert, Andrea Varga, Marcia S. Brose, Rahul Aggarwal, Chia-Chi Lin
BMC Cancer. 2019-03-04 - 61 citationsA Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J. Galloway, Lori J. Wirth, A.D. Colevas, Jill Gilbert, Julie E. Bauman
Clinical Cancer Research. 2015-04-01 - 319 citationsE1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcin...Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao
Journal of Clinical Oncology. 2017-02-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: